Abstract:Background Systemic sclerosis (SSc) is a chronic inflammatory disease with complex pathogenesis. The role of regulatory T cells (Tregs) in the development of SSc has started being studied during the last decade with new aspects being disclosed continuously. Although there is a general agreement in the medical literature regarding the decreased functional capacity of circulating Tregs in SSc, the alteration of absolute number of Treg cells as well as orther CD4 +T lymphocyte subsets in SSc is still unclear. Objectives The aim of the present study was to explore the absolute number status of CD4 +T subsets in peripheral blood of patients with SSc using our modified flow cryometric method and investigate whether the imbalance of Th17 and Treg cells can be corrected by supplementing low dose interleukin −2 (IL-2). Methods The peripheral CD4 +T subsets from 54 patients with SSc and 30 healthy control subjects were analysed. The patients were divided into the untreated group (n=29) and treated group (n=25). The patients were also divided into group A (n=28) who only used low-dose glucocorticoids (GCS), and group B (n=26) who also used immunosuppressant cyclophosphamide (CYC), methotrexate (MTX), leflunomide (LEF) or mycophenolate mofetil (MMF). In addition, 21 patients from 54 patients, given a small dose of IL-2 (50WIU) treatment for a 5 day course, divided into pre-treatment group and post-treatment group. Directly using the results from flow cytometry combined with internal standard beads, absolute number of peripheral CD4 +T subsets from the subjects in each group were calculated. Results Although there were some changes among CD4 +T cell subsets in peripheral blood from these SSc patients, the major alteration was the reductions of Treg cell absolute number. Compared with the normal controls, the number of CD4+CD25+FOXP3+Treg cells were significantly decreased in all patients (p=0.001), in untreated group (p=0.029), in treated group (p=0.029), in group A (p=0.006) and in group B (p=0.004). The ratio of Th17/Treg in total patients (p=0.008) and group B (p=0.001) were significantly higher than that in normal control group, and the group B was significantly higher than the group A (p=0.032). Moreover, the number of Th17 cells in group B was significantly higher than that in group A (p=0.023). After IL-2 treatment, the absolute number of CD4+CD25+FOXP3+Treg cells (p 0.05). Since Th17 cells increases significantly lower than Treg cells, so their ratio decreases significantly (p=0.001) to get re-balance. Conclusions The absolute number of peripheral CD4 +CD25+FOXP3+Treg cells decreased in untreated patients, indicating that this reduction arising from the disease itself. Our findings suggest that SSc progression is associated with the absolute decrease of peripheral Treg cells. Although there was no statistically significant different, absolute number of the Treg cells trended to decrease in patients treated with immunosuppressive agents. The use of IL-2 can effectively up-regulate Treg cells as well as increase Th17 to a certain extent, which restores the balance of Th17/Treg cells, but the long-term effect needs further investigation. Disclosure of Interest None declared

Responsive Characteristics of IL-7 and TGF-β1 in Thymus During Exercise-induced Immunosuppression

THU0412 Absolute reduction of peripheral cd4 + regulatory t cell subset of patients with systemic sclerosis and its restoration by short-term and low dose il-2 treatment

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

SAT0163 Absolute Number of Peripheral Cd4-Cd25+foxp3+t Cells Decreases and Restores after Low-Dose Interleukin-2 Treatment in Rheumatoid Arthritis

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4<sup>+</sup>CD25<sup>+</sup>and CD8<sup>+</sup>regulatory T cell subsets

A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

A Regulatory Role for IL-10 Receptor Signaling in Development and B Cell Help of T Follicular Helper Cells in Mice

Recirculating Th2 Cells Induce Severe Thymic Dysfunction Via IL-4/STAT6 Signaling Pathway

Exercise, autoimmune diseases and T-regulatory cells

Treadmill exercise promotes interleukin 15 expression in skeletal muscle and interleukin 15 receptor alpha expression in adipose tissue of high-fat diet rats

Characteristics of CD8+CD25- cells induced to become suppressor cells ex-vivo with IL-2 and TGF-β (89.34)

Thymosin-alpha1 Promotes the Apoptosis of Regulatory T Cells and Survival Rate in Septic Mice

Regulatory Activity of Activated Murine Peripheral Cd4(+)Cd25(-) T Cells: A Possible Mechanism of Feedback Regulation on Adaptive Immunity

IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt

[Proliferation of CD4+ CD25+ Regulatory T Cells of Rat by Different Cytokines in Vitro].

Interleukin 35 Induced Th2 and Tregs Bias under Normal Conditions in Mice

[Mechanism Underlying IL-2 Inhibition on T Cell Specific Immune Response].

Critical Role for Thymic CD19+CD5+CD1dhiIL-10+ Regulatory B Cells in Immune Homeostasis.

The Role of the Combination of IL-2 and TGF-beta or IL-10 in the Generation and Function of CD4+ CD25+ and CD8+ Regulatory T Cell Subsets.

Retinoic Acid, IL-2 and TGF-β can Rapidly Induce Naïve Human CD4+ Cells to Become CD25+Foxp3+ Regulatory Cells with Protective Activity in vivo